[Examination of inhibitory effect, safety and usefulness of SN-307 (ondansetron) administered orally once daily for 3-5 consecutive days on nausea and emesis associated with non-platinum anti-cancer drugs].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples